Intervention for decreasing excessive acetaminophen use in Pennsylvania Medicaid recipients

American Journal of Health-System Pharmacy

Volumn 61, Issue 22, 2004, Pages 2410-2414

  Zuckerman, Ilene H ^a   Menis, Mikhail ^a   McNally, Diane L ^b   Layne, Barbara A ^c   Mullins, C Daniel ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b School of Pharmacy   (United States)

^c Pennsylvania Medical Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL; ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG USE; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES; DRUG UTILIZATION; INSURANCE; MIDDLE AGED; OUTCOME ASSESSMENT; STANDARD; STATISTICS; UTILIZATION REVIEW;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; DRUG UTILIZATION; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICAID; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PENNSYLVANIA; PHYSICIAN'S PRACTICE PATTERNS;

EID: 15544382390     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.22.2410     Document Type: Article

References (29)

1. Matzke GR. Nonrenal toxicities of acetarainophen, aspirin, and nonsteroidal anti-inflammatory agents. Am J Kidney Dis. 1996; 28(1, suppl 1):S63-70.
2. Makin AJ, Williams R. Acetaminophen-induced hepatotoxicity: predisposing factors and treatments. Adv Intern Med. 1997; 42:453-83.
3. The management of chronic pain in older persons. AGS Panel on Chronic Pain in Older Persons. American Geriatrics Society. J Am Geriatr Soc. 1998; 46:635-51.
4. Shimp LA. Safety issues in the pharmacologic management of chronic pain in the elderly. Pharmacotherapy. 1998; 18:1313-22.
5. Ruoff G. Management of pain in patients with multiple health problems: a guide for the practicing physician. Am J Med. 1998; 105(1B):53S-60S.
6. Schnitzer TJ. Non-NSAID pharmacologic treatment options for the management of chronic pain. Am J Med. 1998; 105(1B):45S-52S.
7. National Kidney Foundation. Analgesics and your kidneys, www.kidney.org/ general/atoz/content/analgesics.html (accessed 2001 Feb 20).
8. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of Osteoarthritis of the hip and knee. Arthritis Rheum. 2000; 43:1905-15.
9. Chronic pain management in the long-term care setting. Columbia, MD: American Medical Directors Association; 1999.
10. Cramer GW, Galer BS, Mendelson MA et al. A drug use evaluation of selected opioid and nonopioid analgesics in the nursing facility setting. J Am Geriatr Soc. 2000; 48: 398-404.
11. Drugs for pain. Med Lett Drugs Ther. 2000; 42:73-8.
12. McEvoy GK, ed. AHFS drug information 2000. Bethesda, MD: American Society of Health-System Pharmacists; 2000.
13. Poisindex managements: acetaminophen. 2002. http://healthcare.micromedex. com (accessed 2003 Jan 25).
14. Rumore MM. Influence of age-dependent pharmacokinetics and metabolism on acetaminophen hepatotoxicity. J Pharm Sci. 1992; 81:203-7.
15. McClain CJ, Kromhout JP, Peterson FJ et al. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA. 1980; 244: 251-3.
16. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and ethanol use. JAMA. 1994; 272: 1845-50.
17. Johnston SC, Pelletier LL Jr. Enhanced hepatotoxicity of acetaminophen in the alcoholic patients: two case reports and a review of the literature. Medicine. 1997; 76(3):185-91.
18. Schiodt FV, Rochling FA, Casey DL et al. Acetaminophen toxicity in an urban county hospital. N Engl J Med. 1997; 337: 1112-7.
19. Ostapowicz G, Fontana RJ, Schiodt FV et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002; 137:947-54.
20. Barker JD, de Carle DJ, Anuras S. Chronic excessive acetaminophen use and liver damage. Ann Intern Med. 1977; 87:299-301.
21. Heaton PC, Cluxton RJ, Moomaw CJ. Acetaminophen overuse in the Ohio Medicaid population. J Am Pharm Assoc. 2003; 43:680-4.
22. Soumerai SB, Lipton HL. Computer-based drug-utilization review-risk, benefit, or boondoggle? N Engl J Med. 1995; 332:1641-5.
23. Schaffner W, Ray WA, Federspiel CF et al. Improving antibiotic prescribing in office practice. A controlled trial of three educational methods. JAMA. 1983; 250:1728-32.
24. Zimmerman DR, Collins TM, Lipowski EE et al. Evaluation of a DUR intervention: a case study of histamine antagonists. Inquiry, 1994; 31:89-101.
25. Hennessy S, Strom BL, Lipton HL et al. Drug utilization review. In: Strom BL, ed. Pharmacoepidemiology. 3rd ed. New York: Wiley; 2002:505-23.
26. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing." N Engl J Med. 1983; 308:1457-63.
27. Soumerai SB, Majumdar S, Lipton HL. Evaluating and improving physician prescribing. In: Strom BL, ed. Pharmacoepidemiology. 3rd ed. New York: Wiley; 2002:483-503.
28. Hennessy S, Bilker WB, Zhou L et al. Retrospective drug utilization review, prescribing errors, and clinical outcomes. JAMA. 2003; 290:1494-9.
29. Lau HS, de Boer A, Beuning KS et al. Validation of pharmacy records in drug exposure assessment. J Clin Epidemiol. 1997; 50:619-25.